文献速递胰腺与胆道疾病消化道肿瘤与早癌

免疫细胞产生的白细胞介素17诱导胰腺上皮内瘤变细胞的干细胞特征

Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells.
PubMed 文献 · Gastroenterology · 2018-03-29

研究利用KCiMist和KPC小鼠及65例人胰腺肿瘤标本,发现免疫细胞来源的IL17通过上调DCLK1、POU2F3、ALDH1A1和IL17RC调控胰腺癌前病变细胞的干细胞特征;人胰腺肿瘤中DCLK1高表达者中位生存期17.7个月,低于低表达者的26.6个月。

要点

  • IL17中和抗体或缺乏IL17分泌免疫细胞的小鼠,PanIN细胞干细胞相关基因表达模式消失,DCLK1和POU2F3表达显著降低。
  • 过表达IL17的KCiMist小鼠形成更多PanIN,且DCLK1阳性细胞增多。
  • 人胰腺肿瘤中DCLK1高表达者中位生存期17.7个月,低表达者26.6个月。

核心结论

  • 在小鼠和人胰腺肿瘤及癌前病变研究中,免疫细胞来源的IL17通过上调DCLK1、POU2F3、ALDH1A1和IL17RC调控簇细胞发育及胰腺癌细胞干细胞特征。
  • 作者认为,干扰该通路的策略可能被开发用于预防胰腺肿瘤生长和进展。

研究设计与样本

  • 研究使用Mist1Cre;LSLKras;Rosa26mTmG(KCiMist;G)小鼠和Kras(G12D);Trp53(R172H);Pdx1-Cre(KPC)小鼠及其对照同窝小鼠,部分小鼠注射IL17A中和抗体或对照抗体。
  • 通过谱系追踪和流式细胞术分离PanIN上皮细胞并比较基因表达谱,KPC小鼠胰腺肿瘤细胞与IL17或对照培养基孵育后检测基因表达并注入免疫健全小鼠观察肿瘤生长。
  • 通过腺病毒载体在KCiMist小鼠胰腺过表达IL17A,收集所有小鼠胰腺进行组织学和免疫组化分析。
  • 用siRNA或shRNA敲低KPC胰腺癌细胞中DCLK1等蛋白,并行免疫印迹分析。
  • 获取65例患者胰腺肿瘤标本,免疫组化分析蛋白水平并与患者生存时间比较,同时利用癌症基因组图谱数据库分析基因表达水平与患者结局。

主要发现

  • KCiMist;G小鼠的PanIN细胞具有与胚胎干细胞相关的基因表达模式;注射IL17中和抗体或缺乏IL17分泌免疫细胞的小鼠该表达模式消失,DCLK1和POU2F3表达显著降低。
  • 过表达IL17的KCiMist小鼠较对照小鼠形成更多PanIN,且DCLK1阳性细胞更多。
  • KPC小鼠胰腺肿瘤细胞和人Capan-2细胞经IL17A处理后,较对照培养基中细胞NF-κB和丝裂原活化蛋白激酶信号活化增加,DCLK1和ALDH1A1表达增加。
  • 经IL17A处理的细胞注入免疫健全小鼠后,较未暴露于IL17的细胞成瘤更快。
  • 敲低DCLK1的KPC细胞经IL17孵育后ALDH1A1水平低于未敲低细胞;小鼠DCLK1阳性PanIN细胞IL17受体C表达高于DCLK1阴性PanIN细胞。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Little is known about how the immune system affects stem cell features of pancreatic cancer cells. Immune cells that produce interleukin 17A (IL17A) in the chronically inflamed pancreas (chronic pancreatitis) contribute to pancreatic interepithelial neoplasia (PanIN) initiation and progression. We investigated the effects that IL17A signaling exerts on pancreatic cancer progenitor cells and the clinical relevance of this phenomena. METHODS: We performed studies with Mist1Cre;LSLKras;Rosa26mTmG (KCiMist;G) and Kras(G12D);Trp53(R172H);Pdx1-Cre (KPC) mice (which upon tamoxifen induction spontaneously develop PanINs) and control littermates. Some mice were injected with neutralizing antibodies against IL17A or control antibody. Pancreata were collected, PanIN epithelial cells were isolated by flow cytometry based on lineage tracing, and gene expression profiles were compared. We collected cells from pancreatic tumors of KPC mice, incubated them with IL17 or control media, measured expression of genes regulated by IL17 signaling, injected the cancer cells into immune competent mice, and measured tumor growth. IL17A was overexpressed in pancreata of KCiMist mice from an adenoviral vector. Pancreata were collected from all mice and analyzed by histology and immunohistochemistry. Levels of DCLK1 and other proteins were knocked down in KPC pancreatic cancer cells using small interfering or short hairpin RNAs; cells were analyzed by immunoblotting. We obtained 65 pancreatic tumor specimens from patients, analyzed protein levels by immunohistochemistry, and compared results with patient survival times. We also analyzed gene expression levels and patient outcome using The Cancer Genome Atlas database. RESULTS: PanIN cells from KCiMist;G mice had a gene expression pattern associated with embryonic stem cells. Mice given injections of IL17-neutralizing antibodies, or with immune cells that did not secrete IL17, lost this expression pattern and had significantly decreased expression of DCLK1 and POU2F3, which regulate tuft cell development. KCiMist mice that overexpressed IL17 formed more PanINs, with more DCLK1-positive cells, than control mice. Pancreatic tumor cells from KPC mice and human Capan-2 cells exposed to IL17A had increased activation of NF-κB and mitogen-activated protein kinase signaling and increased expression of DCLK1 and ALDH1A1 (a marker of embryonic stem cells) compared with cells in control media. These cells also formed tumors faster that cells not exposed to IL17 when they were injected into immunocompetent mice. KPC cells with knockdown of DCLK1 expressed lower levels of ALDH1A1 after incubation with IL17 than cells without knockdown. Expression of the IL17 receptor C was higher in DCLK1-positive PanIN cells from mice compared with DCLK1-negative PanIN cells. In human pancreatic tumor tissues, high levels of DCLK1 associated with a shorter median survival time of patients (17.7 months, compared with 26.6 months of patients whose tumors had low levels of DCLK1). Tumor levels of POU2F3 and LAMC2 were also associated with patient survival time. CONCLUSIONS: In studies of mouse and human pancreatic tumors and precursors, we found that immune cell-derived IL17 regulated development of tuft cells and stem cell features of pancreatic cancer cells via increased expression of DCLK1, POU2F3, ALDH1A1, and IL17RC. Strategies to disrupt this pathway might be developed to prevent pancreatic tumor growth and progression.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Zoltan M, Riquelme E, et al. Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells. Gastroenterology. 2018. PMID: 29604293. doi:10.1053/j.gastro.2018.03.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。